| Esophageal Adenocarcinoma investigated in trials for …INVESTIGATED_IN_TRIALSderived15 of 51show all (up to 200) |
|---|
| → investigated in trials for | Fluorouracilsmall molecule 25 trials (8 active) · roll-up of the cancer and its descendants | — | — | Esophageal Adenocarcinoma | 25 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Oxaliplatinsmall molecule 24 trials (10 active) · roll-up of the cancer and its descendants | — | — | Esophageal Adenocarcinoma | 24 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Leucovorinsmall molecule 18 trials (7 active) · roll-up of the cancer and its descendants | — | — | Esophageal Adenocarcinoma | 18 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Paclitaxelsmall molecule 18 trials (11 active) · roll-up of the cancer and its descendants | — | — | Esophageal Adenocarcinoma | 18 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carboplatinsmall molecule 12 trials (6 active) · roll-up of the cancer and its descendants | — | — | Esophageal Adenocarcinoma | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pembrolizumabmonoclonal antibody 12 trials (5 active) · roll-up of the cancer and its descendants | — | — | Esophageal Adenocarcinoma | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nivolumabmonoclonal antibody 11 trials (10 active) · roll-up of the cancer and its descendants | — | — | Esophageal Adenocarcinoma | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Capecitabinesmall molecule 10 trials (9 active) · roll-up of the cancer and its descendants | — | — | Esophageal Adenocarcinoma | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cisplatinsmall_molecule 9 trials (3 active) · roll-up of the cancer and its descendants | — | — | Esophageal Adenocarcinoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trastuzumabmonoclonal antibody 7 trials (4 active) · roll-up of the cancer and its descendants | — | — | Esophageal Adenocarcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Durvalumabmonoclonal antibody 6 trials (4 active) · roll-up of the cancer and its descendants | — | — | Esophageal Adenocarcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Irinotecansmall molecule 6 trials (4 active) · roll-up of the cancer and its descendants | — | — | Esophageal Adenocarcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Docetaxelsmall molecule 5 trials (3 active) · roll-up of the cancer and its descendants | — | — | Esophageal Adenocarcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ramucirumabmonoclonal antibody 5 trials (3 active) · roll-up of the cancer and its descendants | — | — | Esophageal Adenocarcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tremelimumabmonoclonal antibody 5 trials (3 active) · roll-up of the cancer and its descendants | — | — | Esophageal Adenocarcinoma | 5 | Observed | clinicaltrials | graph → |